Communiqués Carasent AB

Actions

CARAO

SE0023261599

Equipement et technologie médicale avancés

Temps réel estimé Cboe Europe 14:26:34 22/09/2026			Varia. 5j.	Varia. 1 janv.
25,98 ^SEK	-0,86%		-3,17%	-5,28%

14/09	Lannebo Hälsa och Ny Teknik progresse de 5,9 % en août - Bico parmi les gagnants du mois	FW
04/09	Origo Quest a progressé de 3,6 % en août - FLS a contribué positivement après un rapport solide	FW

Communiqués

13/07	Carasent (Q2 Review): Positive momentum in several key areas	AQ
13/07	Carasent: Initiatives in Infosolutions the biggest highlight – Q2 review	AQ
10/07	Carasent (Q2 Initial take): Solid Q2 in line with expectations	AQ
10/07	Carasent: Solid report with continued ARR strength – Q2 initial	AQ
10/07	Carasent () : interim report Q2 2026	PU
10/07	Carasent AB (publ) – interim report Q2 2026	AQ
03/07	Carasent () : Invitation to presentation of Q2 2026 results	PU
03/07	Carasent AB (publ) – Invitation to presentation of Q2 2026 results	AQ
24/06	Carasent: Infosolutions adds another layer to the story – Q2 preview	AQ
09/06	Carasent completes the acquisition of Infosolutions	AQ
29/05	Change in the number of shares and votes in Carasent AB (publ)	AQ
27/04	Carasent: Broadening with lab solution in Sweden	AQ
27/04	Carasent: Announces acquisition of Infosolutions	AQ
27/04	Carasent acquires Infosolutions and strengthens its position in Swedish private healthcare	AQ
20/04	Annual General Meeting in Carasent AB (publ)	AQ
15/04	Carasent (Q1 review): Medsum momentum and German milestone	AQ
15/04	Carasent: Focus on recurring revenue – Q1 review	AQ
14/04	Carasent (Q1 initial take): Strong ARR, but profitability below expectations on higher costs and softer consulting	AQ
14/04	Carasent: Miss on headline but recurring revenue strong – Q1 initial	AQ
14/04	Carasent : Q12026 En	PU
14/04	Carasent : Q1 2026 Presentation	PU
14/04	Carasent AB (publ) – interim report Q1 2026	AQ
08/04	Carasent () : Invitation to presentation of Q1 2026 results	PU
08/04	Carasent AB (publ) – Invitation to presentation of Q1 2026 results	AQ
31/03	Carasent: Ticks a lot of boxes in an uncertain environment – Q1 preview	AQ